Regulatory Considerations for Medtech Startup Growth

 

In episode 151 of the Project Medtech Podcast, Nikki Batista, Devon Campbell, and host Duane Mancini discuss the merger of regulatory and business strategy, allowing business to lead decisions not regulatory, global regulatory strategy, how to communicate with the FDA, and so much more.

Part 1 in a three-part series where Devon and Duane explore tips to help startups set up their company to be investable, acquirable, and successful.

 
 
Previous
Previous

Navigating IP and Trade Secrets issues for Medtech startups

Next
Next

Medtech Funding and Preparing for Due Diligence